enGene Therapeutics Inc (ENGN) vs Nautilus Biotechnology, Inc. (NAUT)
enGene Therapeutics Inc and Nautilus Biotechnology, Inc. are both Biotechnology companies. enGene Therapeutics Inc and Nautilus Biotechnology, Inc. are of similar size ($128.7M and $126.1M). Across the 10 metrics below, Nautilus Biotechnology, Inc. leads on 6 and enGene Therapeutics Inc on 4.
Valuation
Profitability
| Metric | ENGN | NAUT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (60.50%) | (36.21%) | (57.72%) |
| Return on assets | (48.84%) | (30.00%) | (49.22%) |
| Return on invested capital | 0.00% | (83.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack